Genentech

South San Francisco, Californiagene.com1expert edge

Biotechnology company focused on drug development and biopharmaceutical research. Founded in 1976 as the world's first biotechnology company and is now a wholly-owned subsidiary of Roche.

Why interesting to a deal team

Ian Wijaya's Lazard team advised on Roche's $46.8 billion full acquisition of Genentech (2009), exemplifying deep expertise in large-scale biotech M&A transactions and value realization.

Experts connected to this company

Ian WijayaLazard team advised on Roche's $49bn squeeze-out

Ian Wijaya

Managing Director, Co-Head North America Healthcare

Lazard

BankerNew York

Co-head of Lazard's healthcare practice with a $250bn+ deal record on payer, PBM, and biopharma megadeals — a top sell-side gatekeeper for platform-scale healthcare exits.

Sources

Page titleOther
en.wikipedia.org/wiki/Genentech
Page titleOther
gene.com

Strongest evidencePage title2 public sourcesHow the grades work